COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.

Saved in:
Bibliographic Details
Title: COX-2 potentiates cisplatin resistance of non-small cell lung cancer cells by promoting EMT in an AKT signaling pathway-dependent manner.
Authors: Jiang GB; Department of Oncological Surgery, Taizhou Enze Medical Center (Group) Enze Hospital, Zhejiang, China. caofl@enzemed.com., Fang HY, Tao DY, Chen XP, Cao FL
Source: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2019 May; Vol. 23 (9), pp. 3838-3846.
Publication Type: Journal Article
Journal Info: Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2284-0729
DOI:10.26355/eurrev_201905_17811